On September 19, 2022, AIM ImmunoTech Inc. filed a definitive proxy statement soliciting proxies and urged the shareholders to vote for the election of its nominees, Thomas K. Equels, William M. Mitchell, and Stewart L. Appelrouth, as directors of the Company at the Company's annual shareholders meeting scheduled to be held on November 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4282 USD | +5.34% | -7.91% | -2.66% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.66% | 20.28M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- AIM Stock
- News AIM ImmunoTech Inc.
- AIM ImmunoTech Solicits Proxies from Shareholders